centre with interdisciplines of a respiratory physician, nurse, physiotherapists and occupational therapist. Regular sessions on education, exercise tolerance training, energy conservation and stress management training were given. Pre and post PRP outcomes included: body weight; body mass index; CAT score; puff technique; lung function test; 6-minute walk distance (6MWD); Chronic Respiratory Disease Questionnaire (CRQ); Shortness of breath questionnaire and Hospital anxiety and depression score were collected.
Conclusion: PR was beneficial in improving drugs administration, relieving symptoms, enhancing health-related quality of life and increasing exercise capacity of COPD patients being identified in primary care clinics. Background and Aims: Inhalation of air pollutant NO 2 leads to progressive airflow limitation and emphysema-like lesions, but the underlying mechanisms were not fully understood.
Methods: Male SD rats were continuously exposed to NO 2 at a concentration of 20 ppm or normal air on fixed occasion. During the rest periods, all rats breathed normal air. Pulmonary function (PF), haematological parameters, and biochemical tests were examined at the 14th, 45th, and 75th days of NO 2 exposure in anesthetized rats. After 75 days of NO 2 inhalation, NaHS, 5-AZA(5-Azacytidine) or NaCl treatment were carried out for one month (day 76th to 105th) to evaluate their effect on the rats.
Results: Compared with normal air exposure control, at 75th days of NO 2 exposure, a significant decrease in FEV1/FVC% as well histologic evidence of emphysema were found in the rats; NO 2 could led to increased GLU (Glucose), Triglyceride (TG), RBC (Red blood cell), HGB (Haemoglobin), and HCT (Haematocrit). After NO2 cessation, PF test showed no further deterioration in all three treatments compared to controls, respectively. Compared with NaCl, 5-AZA treatment had the ability to increase levels of GLUv and PLT (Platelets) significantly, and decrease HGB and HCT; with NaHS, Granulocyte and Lymphocyte together with HDL-C levels were greatly elevated.
Conclusion: These findings suggested that NO 2 exposure caused emphysema, PF decline and blood increase of GLU in rats. All three treatments could prevent PF decline further. In addition, demethylation therapy with 5-AZA inhibited the increase of blood GLU; whereas, antioxidative stress therapy with NaHS could reinforce immune function of rats but not increase of blood GLU. Background and Aims: COPD is a well-known risk factor for the development of lung cancer, independent of smoking behaviour. However, the environmental risk factors contributing to the development of lung cancer is not well researched except for smoking history and COPD.
Therefore, we attempted to examine the prevalence of lung cancer in COPD and the environmental factors associated with the development of lung cancer in National Health Insurance Service-National Sample Cohort (NHIS-NSC).
Methods: NHIS-NSC is a population-based cohort established by NHIS in South Korea. Among 514,866 subjects of NHIS-NSC, 23,506 patients who were diagnosed with any cancer from 2002 to 2003 were excluded. We enlisted 324,621 never-smokers (male = 31.3%), 46,802 ex-smokers (male = 93.4%), and 120,056 smokers (male = 89.6%) and investigated the prevalence and factors associated with the development of lung cancer for 12 year observation period.
Results: Lung cancer developed in 2.83% of never-smokers with COPD, 5.16 % of former smokers of COPD, and 7.04% of smokers with COPD for 12 year period. Age, male gender, history of diabetes, exercise level, and COPD in smokers and never smokers were independent risk factors associated with the development of lung cancer (P<0.05).
Conclusion: Our data suggest that age, male gender, history of diabetes, exercise level, and COPD in smokers and never smokers were independent risk factors associated with the development of lung cancer. Methods: We collected COPD families to do the whole genome sequencing and performed SNP detection and annotation on the whole genome sequencing data. Then filtered through the database to select the missense sites located in exons were shared between two or more families for subsequent verification. COPD and non-COPD groups based on pulmonary function, inclusion, and exclusion criteria were recruited.
We did the validation by doing the association analysis. Western blotting was used to detect the protein level and real time-PCR was used to detect the mRNA level; Small interfering RNA (siRNA) was used to silence Cbl-b gene expression, and lentiviral gene expression vector was used to over-express Cbl-b gene.
Results: We collected a total of 11 COPD patients from 5 COPD families. The average sequencing depth was more than 30× and the coverage was over 99% of the total genome length. After the advanced analysis, 18 SNP candidate sites were finally obtained.
A total of 1589 subjects were recruited (COPD 656, non-COPD 933). There was no significant difference in gender and age between the two groups. The smoking index, lung function, and body mass index were
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